Neural Therapeutics Inc. (CSE:NURL)

Market Cap	2.53M
Revenue (ttm)	n/a
Net Income (ttm)	-1.41M
Shares Out	168.70M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,402,583
Average Volume	384,664
Open	0.0200
Previous Close	0.0150
Day's Range	0.0150 - 0.0200
52-Week Range	0.0150 - 0.0500
Beta	n/a
RSI	30.64
Earnings Date	Nov 21, 2025

About Neural Therapeutics

Neural Therapeutics Inc., a drug discovery company, focuses on plant-based active substances. It focuses on San Pedro, a cactus containing mescaline and delivers over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments. Neural Therapeutics Inc. was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in November 2021. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2020
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: NURL